Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company, The Home Depot and ...

Eli Lilly’s revenue has soared in recent years thanks to its leadership in the weight loss drug market. Eli Lilly (NYSE: LLY) ...

Eli Lilly and Company (NYSE: LLY) is one of the 17 stocks that Jim Cramer commented on. Cramer showed a positive sentiment ...

Eli Lilly and Company (NYSE:LLY) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. Analyst Asad Haider from ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

The two products accounted for about 48% of Eli Lilly's most recent quarterly sales and drove most of the top-line growth.

Eli Lilly continues to dominate the obesity market with Zepbound and Orforglipron, leading JPMorgan to see it as a top pick ...

Companies are always in the race for the top spot, and the only way to achieve it is by reaching a high market valuation. The ...

Shares of Eli Lilly & Co. LLY rallied 4.33% to $807.19 Tuesday, on what proved to be an all-around positive trading session ...

ConocoPhillips (NYSE:COP) is one of the 14 stocks on Jim Cramer’s radar. A caller mentioned that they have been thinking of ...

Eli Lilly will be presenting data from studies on multiple GLP-1 drugs later this month. Encouraging data on GLP-1 treatments in its pipeline could help give the stock a big boost. Concerns about ...

Benzinga examined the prospects for many investors' favorite stocks over the last week — here's a look at some of our top stories.